Error message

  • Deprecated function: Creation of dynamic property MergeQuery::$condition is deprecated in MergeQuery->__construct() (line 1357 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).

Zydus Cadila wins USFDA Nod for Hydroxychloroquine Sulphate Pills

Sumeet Kak 26 September 2007

Zydus Cadila
Chennai: Cadila Healthcare Ltd has received USFDA approval for hydroxychloroquine sulphate tabs in the strength of 200 mg.

The medicine falls under the DMARD (disease modifying anti-rheumatic drug) section, and is used in caring rheumatoid arthritis.

According to NDC Health, the sales of such pills in the US market in 2006 stood at $30 million.

The pharmaceutical giant will promote the medication through its US subsidiary, Zydus Pharmaceuticals (USA) Inc.

Since the beginning of filing route in 2003-04, the group has got 27 approvals. Up to now, it has registered 65 ANDAs and 55 DMFs.

Business News: 
Company Updates
Pharmaceutical Sector
Regions: 
United States

Error | TopNews

Under Maintenance

The website encountered an unexpected error. Please try again later.